Indo US Bio-Tech
Indo US Bio-Tech Share Price Chart
Indo US Bio-Tech last traded at ₹72.00 (2026-10-13). Over the past month the stock moved -7.2%, three months the stock moved -28.7%, year the stock moved -50.5%. Its closing range over 52 weeks is ₹72.00 – ₹150.40, with the latest close 52.1% below the high.
Closing prices up to 2026-10-13.
About Indo US Bio-Tech
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]
Business Overview:[1] IUBTL is involved in crop Research and Development through breeding, seed production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Indo US Bio-Tech reported sales of ₹32.99 crore (+7.2%) and net profit of ₹3.04 crore (-35.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 32.99 | 3.97 | 12.03 | 3.04 | 1.52 |
| Mar 2026 | 26.02 | 3.23 | 12.41 | 1.97 | 0.98 |
| Dec 2025 | 22.80 | 4.15 | 18.20 | 3.00 | 1.50 |
| Sep 2025 | 30.85 | 4.16 | 13.48 | 3.45 | 1.72 |
| Jun 2025 | 30.77 | 5.47 | 17.78 | 4.70 | 2.34 |
| Mar 2025 | 33.38 | 4.58 | 13.72 | 3.68 | 1.84 |
| Dec 2024 | 23.56 | 5.54 | 23.51 | 5.05 | 2.52 |
| Sep 2024 | 22.17 | 5.12 | 23.09 | 4.36 | 2.17 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +40.2% | +6.6% | +111.7% | +24.5% | +39.2% | -3.2% | -22.0% | +7.2% |
| Operating profit growth | +96.9% | +31.0% | +367.3% | +48.2% | -18.8% | -25.1% | -29.5% | -27.4% |
| Net profit growth | +161.1% | +37.2% | +607.7% | +48.3% | -20.9% | -40.6% | -46.5% | -35.3% |
| EPS growth | +161.4% | +37.0% | +607.7% | +48.1% | -20.7% | -40.5% | -46.7% | -35.0% |
| OPM % | 23.1% | 23.5% | 13.7% | 17.8% | 13.5% | 18.2% | 12.4% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Indo US Bio-Tech reported sales of ₹110.00 crore (+5.8%) and net profit of ₹13.00 crore (-18.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 110.00 | 17.00 | 15.00 | 13.00 | 6.54 |
| Mar 2025 | 104.00 | 19.00 | 18.00 | 16.00 | 8.11 |
| Mar 2024 | 73.00 | 11.00 | 15.00 | 8.00 | 4.11 |
| Mar 2023 | 62.00 | 9.00 | 15.00 | 7.00 | 3.60 |
| Mar 2022 | 49.00 | 7.00 | 14.00 | 5.00 | 2.86 |
| Mar 2021 | 39.00 | 6.00 | 14.00 | 5.00 | 3.52 |
| Mar 2020 | 40.00 | 4.00 | 10.00 | 3.00 | 1.74 |
| Mar 2019 | 35.00 | 3.00 | 10.00 | 2.00 | 1.44 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +20.7% | +14.3% | -2.5% | +25.6% | +26.5% | +17.7% | +42.5% | +5.8% |
| Operating profit growth | +0.0% | +33.3% | +50.0% | +16.7% | +28.6% | +22.2% | +72.7% | -10.5% |
| Net profit growth | +100.0% | +50.0% | +66.7% | +0.0% | +40.0% | +14.3% | +100.0% | -18.8% |
| EPS growth | +2.1% | +20.8% | +102.3% | -18.8% | +25.9% | +14.2% | +97.3% | -19.4% |
| OPM % | 10.0% | 10.0% | 14.0% | 14.0% | 15.0% | 15.0% | 18.0% | 15.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Indo US Bio-Tech.
Get Free AI Stock Analysis FREE →Latest News
-
Indo US Bio-Tech passes all five AGM resolutions including auditor appointment - scanx.trade
-
Indo US Bio-Tech appoints Bhagat & Associates as statutory auditors - scanx.trade
-
Indo Us Bio-Tech shareholders approve director regularization and auditor appointment - scanx.trade
-
Indo US Bio-Tech seeks nod for director regularization and auditor appointment - scanx.trade
-
Indo US Bio-Tech Ltd Stock Falls to 52-Week Low of Rs.94
Frequently Asked Questions
What is Indo US Bio-Tech's current stock price?
Indo US Bio-Tech shares were last quoted at ₹72.00 (-2.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Indo US Bio-Tech?
Indo US Bio-Tech has a price-to-earnings (P/E) ratio of 13.59 and a price-to-book (P/B) ratio of 4.52. The industry P/E is 22.85.
What is the 52-week high and low of Indo US Bio-Tech?
The 52-week high of Indo US Bio-Tech is ₹158.85 and the 52-week low is ₹72.60.
What is the market cap of Indo US Bio-Tech?
The market capitalisation of Indo US Bio-Tech is about ₹155.64 crore.
How did Indo US Bio-Tech perform in its latest quarterly results?
In the latest quarter (Jun 2026), Indo US Bio-Tech reported sales of ₹32.99 crore (+7.2%) and net profit of ₹3.04 crore (-35.3%), compared with the same quarter last year.
Is Indo US Bio-Tech a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Indo US Bio-Tech has a 3-year ROE of 18.00%, 3-year profit growth of 22.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Indo US Bio-Tech?
Promoters hold about 68.29% of Indo US Bio-Tech.
Which sector does Indo US Bio-Tech belong to?
Indo US Bio-Tech belongs to the Agriculture sector.